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A sensitive method for the determination of fluoroquinolones in surface waters 
at trace concentration level is presented. The proposed two-step methodology 
consists in a solid-phase extraction using C-18 membranes followed measurement 
of the emission molecular fluorescence spectra over extracted membrane 
without elution of the analytes. Membrane background signal was removed by 
the used of chemometrics calculations, in addition chemometrics was as well 
used for the direct and simultaneous determination of the studied compounds. 
The method was optimized for the analysis of three fluoroquinolones: enoxacin 
(ENO), norfloxacin (NOR) and ofloxacin (OFLO). The fluorescence of 
these compounds increase drastically when they are into the membrane, 
thus with this method low concentrations are possible to be determined, as 
the concentration in which these compounds appear in surface water. Limits 
of detection at the ng · L-1 level were estimated for ENO, NOR and OFLO.
Keywords: fluoroquinolones, emerging contaminants, surface water, chemomet-
rics, fluorescence.
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Introduction
Fluoroquinolones are an important group of broad-spectrum synthetic 
antibacterial agents derived from nalidixic acid, present a potent effect against 
different gram (-) bacteria [1]. The great advantage of these drugs, in order to 
activity and spectral characteristics, is due to the presence of a fluorine atom in 
position six of the quinolonic ring (Fig. 1). The introduction of the fluorinated 
quinolones represents important therapeutic advantages, because this group of 
antibiotics shows higher antibacterial activity than parent compounds [2]. They 
are used to treat human and veterinary diseases and also to prevent diseases in 
food producing animals [3, 4]. Their main excretion pathway is urinary and low 
amounts are found in plasma [5]. 
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Fig. 1. Structures of the studied analytes.
Urinary or faecal excretions introduce human pharmaceuticals into waste-
water. Veterinary drugs result in a direct input to soils and subsequently to 
groundwater. Moreover, the use of veterinary drugs in fish farming activities 
leads to their direct entrance into the aquatic environment. Several pharmaceu-
ticals can be degraded in human and veterinary body, but others are excreted 
in their active forms. In that sense, antibiotics assume special significances 
due to their occurrence in the environment may contribute to the develop-
ment of drug resistant bacterial strains. Fluoroquinolones are excreted mostly 
unchanged [6]. 
Many pharmaceuticals have been detected (at the low range of nano-
grams up to micrograms per litre) in the environment [7, 8]. That means the 
procedures for wastewater treatment are not able to completely remove these 
compounds. Ofloxacin (OFLO) and norfloxacin (NOR) are among the fluoro-
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quinolones most frequently detected in wastewater effluents around the world 
[9 – 11]. Although such low concentrations are probably not active to humans, 
they are potentially hazardous to bacteria and other micro-organisms. Fluoro-
quinolones may be directly toxic or be the source of resistant human pathogens 
representing a possible risk to human health [12]. 
The importance of this antibiotic group is highlight by the huge numbers 
of reviews and articles published in the last decade. The studies are performed 
in different matrices such as biological fluids, pharmaceuticals, feeds and envi-
ronmental samples [9, 13, 14]. 
To evaluate the fate of these drug residues and to control the quality of the 
aquatic medium, sensitive analytical methods are needed. The high fluorescence 
quantum yield exhibited by quinolones and fluoroquinolones allow us highly 
sensitivite detection. Among the analytical techniques, Liquid chromatography 
is the most widely applied for the determination of these compounds and both, 
UV and fluorescence detection, are usually employed [8, 15 – 18] and, also, mass 
spectrometry detection [19]. For multi-residue analysis, sample pre-treatments 
are necessary to extract drugs with different physical/chemical properties. In 
general, these methods employ solid phase extraction procedures [9].
On the other hand, multivariate techniques have been incorporated to 
the analytical protocols in the last decade [20]. In particular, full-spectrum 
multivariate calibration methods offer the advantage of their speed, because 
the separations steps may be avoided. Analytical methods for determination of 
fluoroquinolones in several matrices using chemometrics have been reported. 
Enoxacin (ENO), OFLO and NOR  was determined in urine samples by partial 
least squares (PLS) coupled to emission molecular fluorescence spectra, the 
limits of detection in urine were 10.0; 0.5 and 0.8 ng ⋅ mL-1, respectively [21]; 
and it was proposed an excitation emission molecular fluorescence technique 
with PARAFAC calibration for enrofloxacin determination in feeding water 
from poultry farms; also proposed a spectrofluorimetric method coupled with 
PARAFAC for danofloxacin determination in milk samples [22], the limit of 
detection was under maximum residues level (MRL) fixed by European Union 
[23]. ENO, OFLO and pefloxacin were analyzed in urine samples [24] by syn-
chronous fluorescence spectroscopy with PLS-1 and using excitation emission 
matrix fluorescence along with N-way partial least squares regression (N-PLS 
and U-PLS). 
All above method has been applied to liquid samples. Solid-phase fluores-
cence spectroscopy permits the development of fast analytical methods, with 
minimum consumption of reagents, low costs for analysis and presents good 
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characteristics of sensitivity and selectivity [25]. Therefore we provide a method 
with high sensitivity via a simple experimental procedure consisting in a solid 
phase extraction and then measuring the emission molecular fluorescence 
spectra over extracted membrane without elution of the analytes. Emission 
molecular fluorescence spectra recorded were processed with a PLS method. 
Experimental
Apparatus and software. Fluorescence measurements were made on a Fluo- 
rolog-3 spectrofluorimeter (ISA, JobinYvon-Spex, model FL3-11), equipped 
with a continuous source (450 W Xenon) for sample excitation.
All calculations were done using MATLAB 7.10 [19]. The routine for PLS-1 
used was written following a previously known algorithm [26].
Reagents. All solvents used were of analytical reagent quality. Enoxacin, 
ofloxacin and norfloxacin were purchased from "Sigma Aldrich" (Madrid, 
Spain). Standard solutions of each compound (100 µg · mL-1) were prepared by 
dilution in ethanol (avoiding exposure to direct light and maintained at 4°C). 
Buffer solution of pH 4 was purchased from "Fisher Scientific" (Madrid), and 
the C-18 membranes from "Agilent" (Madrid).
Solutions preparation. Standards solution of each compounds were pre-
pared by dilution in ethanol. Working solutions were prepared in pure water, 
adjusting the pH to 4 adding 400 µl the buffer solution to 10 ml of sample. To 
keep a minimum ethanol volume ratio in the aqueous solution, highly concen-
trated stock solutions were used. 
Solid phase extraction (SPE). First, the membranes were conditioned with 
2 ⋅ 1 ml of methanol, 1 ⋅ 1 ml of pure water and 1 ⋅ 1 ml of the commercial buf-
fer solution (pH 4). Water sample pH was adjusted to pH 4 and 10 ml of sample 
were percolated through the membrane using a 10 ml glass syringe (Fig. 2). 
Then 3 ⋅ 100 ml of air was percolated through the membrane to dry it. Finally, 
the fluorescence was measured directly in the solid surface.
Fluorescence measurements. The fluorescence spectra were directly reg-
istered from the C-18 membranes after the analyte retention. Membrane disks 
were appropriated placed in the lab-made membrane disk holder [27]. The 
direct measurement produces an important increase of the fluorescence signal 
allowing increasing the sensitivity of the methodology. Fig. 3, shows the sig-
nificant gain of fluorescence produced when the analytes are retained into the 
membrane, being the signal in membrane 200 times higher than in solution for 
ENO, 118 for NOR and 88 for OFLO.
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Fig. 2. Membrane solid-phase extraction device.
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Fig. 3. Emission spectra, for ENO, NOR and OFLO, into the membrane (a), and in 
water solution (b), in the same concentration and instrumentals conditions.
Results and discussion
SPE and membrane retentions. Firstly, the retention capacity of the selected 
membranes was studied based on the amount of analyte effectively retained 
in the membrane. 10 different fluoroquinolones solutions in the range of nor-
floxacin, 0.0 – 80.0 ng · L-1, enoxacin, 0.0 – 200.0 ng · L-1, and ofloxacin, 
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0.0 – 80.0 ng · L-1 were prepared as described above and extracted according 
to the SPE methodology. Fluorescence signal was registered before and after of 
sample percolation through the extraction system, and the membrane retention 
efficiency was calculated by comparing the signals obtained before and after. 
Table 1 summarized the results obtained in this experiment. The recovery val-
ues were from 82 to 94% for the different drugs.
Table 1. Retentions of enoxacin, norfloxacin and ofloxacin into the C-18 membrane*
Analyte λexc /λem **, nm Retentions, %***
Enoxacin 347/386 88.5 ± 1.4
Norfloxacin 332/419 94.3 ± 0.6
Ofloxacin 340/460 82.8 ± 0.2
* Ten millilitres of water sample was used; ** fluorescence excitation (λexc ) and emission (λem ) 
maxima; *** retention was calculated based on fluorescence intensity before and after extraction.
PLS calibration. The PLS-1 method involves a calibration step in which the 
relation between bi-dimensional emission spectra and analyte concentrations 
is estimated from a set of reference samples, and a prediction step in which the 
results of the calibration are used to estimate the component concentrations in 
unknown samples.
A 15 samples set was built for calibration with the PLS-1 model. The analyte 
concentrations corresponded to a central composite design, formed by a three-
component full-factorial design at two levels (i.e. (23) 8 samples, a central point 
(one sample), and a star design (2x3) 6 samples), making a total of 15 samples. 
The extreme concentrations for the design were as follows: norfloxacin 0.0 – 
80.0, enoxacin – 0.0 – 200.0, and ofloxacin – 0.0 – 80.0 ng · L-1.  The membrane 
background was important, so the model was modified in order to obtain better 
results, introducing 10 blank samples. The total number the samples for the cali-
brations was 25; 15 of them corresponds to the central composite design and the 
other 10 to the blank solutions.   
In order to determine the correct number of loading vectors to be used for 
the modeling of the data, a cross-validation calculation for all the samples in 
the training set, was performed to calculate the prediction residual error sum of 
squares (PRESS).  The selection of the number of factors, to be use in the cali-
bration with the PLS algorithm, is very important in order to achieve the best 
predictions for to model the system without overfitting the concentration data. 
To select the optimum number of factors, the criterion proposed by Haaland 
and Thomas was used [26].
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The optimum wavelength ranges were 350 – 550 nm for ENO, 395 – 
445 nm for NOR and 350 – 550 nm for OFLO, using 4 factors in the three 
cases. On the other hand, determination coefficients R2 of 0.9568, 0.9167 and 
0.92491 were calculated for ENO, NOR and OFLO. The poorest results were 
obtained for NOR (Table 2). 
Table 2. Optimum number of factors and calibration statistical parameters by 
applying PLS algorithm to resolve the mixture enoxacin, norfloxacin and ofloxacin 
in C-18 membrane using the emission spectra (λexc= 334 nm) in natural water 
samples
Statistical Parameter Enoxacin Norfloxacin Ofloxacin
Range (nm) 350 – 550 395 – 455 350 – 550
FACTORS 4 4 4
PRESS 3.604 · 103 1.366 · 103 8.997 · 102
R2 0.9568 0.9167 0.92941
The emission spectra were registered between 350 – 550 nm each 0.5 nm, 
and the excitation wavelength was 334 nm. The emission and excitation slits 
were fixed at 1.2 nm (Fig. 4).
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Fig. 4. Excitation and emission spectra in membrane of ENO (1.0 µg/mL), NOR 
(1.0 µg/mL), OFLO (1.0 µg/mL) and the blank signal.
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Analytical figures of merit. The selectivity (SEL), sensitivity (SEN) and 
limit of determination of an analytical method (named figures of merit) to 
determine the quality of an analytical technique can be calculated. Selectiv-
ity can be expressed as:
|| ||1
.
|| |||| || || ||
K
K
k K K
NAS
SEL
b s s
= =
Ranging from 0 to 1 is a measure of how unique the spectrum of the 
analyte of interest is compared with other species. A value of 0, means 
that analysis is impossible because the analyte spectrum is equal to a lin-
ear combination of the interference spectra. A value of 1 indicates that the 
interferences do not interfere. The part of the signal that relates uniquely 
to the analyte of interest is more important than the total signal (sk). This 
unique signal, is named the net analyte signal (NAS) and is a vector related 
to the regression vector b. NASk designates the square root of the sum of 
each element in the b.
Sensitivity is expressed as: 
1
SEN  || NAS || .
|| ||   kkb
= =
And it is proportional to the regression vector, because the inverse calibration 
model is used. The units of sensitivity are signal/concentration. 
Other possibilities are to calculate the limit of detection (LOD) expressed as: 
           
LOD 3 || || || ||,Kb= ⋅ ε ⋅
being  ε the instrumental noise, and it can be calculated from blank signals. 
Table 3 summarized the quality parameters calculated as described above. 
The limits of detection were between 11.0 and 78.1 ng/L. The highest values 
were obtained by the ENO. However, these LODs are adequate for the deter-
mination of these three antibiotics compounds in surface water. For the instru-
mental noise determination, 10 blank samples were used. 
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Table 3. Figures of merit of the analytical method (limit of detection, selectivity and 
sensibility)
Figure of merit Enoxacin Norfloxacin Ofloxacin
LOD* 78.1 15.5 11.0
SEL 0.1915 0.3211 1.359
SEN** 1.955 · 104 3.279 · 104 1.387 · 105
*ng/L; ** FU · L · ng-1.
Analysis of ENO, NOR and OFLO in surface water. The optimized method 
was used to simultaneously determine the concentration of ENO, NOR and 
OFLO from lake water (Orlando, Florida, USA). Water samples were collect-
ing in different point of the lake using appropriate Teflon flasks. Samples were 
filtered and submitted to the analytical procedure. In all cases, no positive 
results were obtained, and therefore samples were spiked with different quanti-
ties of ENO, NOR and OLFO in the range of 20 – 150 ng/L. After the drug 
extraction from spiked water, fluorescence was measured from membranes and 
the PLS method was applied to quantify the fluoroquinolones contents. Table 4 
summarized the results obtained from the different drug and concentration 
level. 
Table 4. Recovery of ENO, NOR and OFLO added to natural water by PLS-1 
calibration
Analyte Added (ng · L-1) Found (ng · L-1) ± R.S.D* % Recovery ± R.S.D*
ENO
150 
80 
70
148.9 ± 4.7 
70.6 ± 2.9 
64.9 ± 1.4
99.7 ± 3.1 
88.8 ± 4.1 
92.7 ±1.9
NOR
40 
20 
30
36.3 ± 1.5 
15.0 ± 2.1 
24.7 ± 2.3
90.7 ± 4.0 
75.2 ± 1.9 
82.3 ± 4.2
OFLO
40 
20 
40
45.3 ± 0.8 
21.0 ± 2.0 
42.5 ± 0.9
113 ± 2.0 
105 ± 4.1 
106 ± 2.3
* Mean of three determinations and R.S.D.: relative standard deviation.
Conclusions
A fast and accurate procedure was proposed to determine fluoroquino-
lones drugs in superficial waters. The high sensitivity obtained by combining 
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a solid-phase extraction using C-18 membranes followed measurement of the 
emission molecular fluorescence spectra over extracted membrane without 
elution of the analytes. PLS chemometric analysis was a practical alternative 
for the simultaneous determination of the studied drugs without further sepa-
ration. In addition, with the aid of chemometrics the background signal was 
adequately removed from the signal. The method was optimized for the analy-
sis of three fluoroquinolones: enoxacin, norfloxacin and ofloxacin. The direct 
fluorescence measurement over the C-18 extraction membrane increased dras-
tically, increasing notoriously the method sensitivity. The calculated LOD for 
the three drugs were in the range of ng/L and therefore this method could be 
feasible to determine these drugs as emerging pollutant in superficial waters. 
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